Joseph N. DiStefano
The Philadelphia Inquirer
Posted with permission from MCT Information Services
The Philadelphia Inquirer
Posted with permission from MCT Information Services
PHILADELPHIA —Drugmaker Endo International P.L.C, run largely from Malvern, Pa., but incorporated in Ireland, said Thursday that it has convinced directors of Auxilium Pharmaceuticals, a Chesterbrook, Pa.-based maker of testosterone-replacement medications, to sell the company for $2.6 billion in cash and debt, including $33.25 (in cash or stock) for each Auxilium share. That\’s a 55 percent…
This post was imported from a legacy archive. Please excuse any formatting inconsistencies.